Sector consensus Changchun BCHT Biotechnology Co.

Equities

End-of-day quote Shanghai S.E. Other stock markets 2026-01-21			5-day change	1st Jan Change
20.56 ^CNY	+3.58%		+0.34%	+9.01%

11-13	BCHT Biotechnology Gets Nod to Trial Vaccines Against Pertussis, Diphtheria, Tetanus	MT
25-10-30	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
CHANGCHUN BCHT BIOTECHNOLOGY CO.	-	-	CN¥32	+61.21%	1
MERCK KGAA			€151.63	+20.77%	16
KYOWA KIRIN CO., LTD.			JP¥2,655	+2.63%	10
HALOZYME THERAPEUTICS, INC.			US$77.13	+9.51%	8
SK BIOPHARMACEUTICALS CO., LTD.			₩145,571.43	+22.12%	14
YUHAN CORPORATION			₩148,555.56	+38.32%	18
INDIVIOR PLC			US$45.57	+38.3%	7
BETTA PHARMACEUTICALS CO., LTD.			CN¥63.79	+32.13%	2
SUPERNUS PHARMACEUTICALS, INC.			US$61.33	+23.11%	6
SHENZHEN CHIPSCREEN BIOSCIENCES CO., LTD.	-	-	-	-	-
DBV TECHNOLOGIES			€4.123	+11.59%	3
KISSEI PHARMACEUTICAL CO., LTD.			JP¥5,000	+6.61%	5
Average			27,474.32	+24.21%	8
Weighted average by Cap.			16,629.26	+20.63%	13